Perioperative outcomes and hospital reimbursement by type of radical prostatectomy: results from a privately insured patient population

Background: With the increasing use of robotic surgery in the United States, the comparative effectiveness and differences in reimbursement of minimally invasive radical prostatectomy (MIRP) and open prostatectomy (ORP) in privately insured patients are unknown. Therefore, we sought to assess the di...

Full description

Saved in:
Bibliographic Details
Published in:Prostate cancer and prostatic diseases 2015-03, Vol.18 (1), p.13-17
Main Authors: Kim, S P, Gross, C P, Smaldone, M C, Han, L C, Van Houten, H, Lotan, Y, Svatek, R S, Thompson, R H, Karnes, R J, Trinh, Q-D, Kutikov, A, Shah, N D
Format: Article
Language:English
Subjects:
631/67/2324
Adult
Biomedical and Life Sciences
Biomedicine
Cancer Research
Cancer surgery
Cancer treatment
Care and treatment
Complications
Diagnosis related groups
DRGs
Hospitalization insurance
Humans
Influence
Insurance, Health, Reimbursement - economics
Length of Stay - economics
Male
Medicare
Methods
Middle Aged
original-article
Patient outcomes
Patients
Perioperative Period
Prostate cancer
Prostatectomy
Prostatectomy - economics
Prostatic Neoplasms - economics
Prostatic Neoplasms - pathology
Prostatic Neoplasms - surgery
Regression analysis
Robotic surgery
Statistics
Surgery
Treatment Outcome
Urological surgery
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: With the increasing use of robotic surgery in the United States, the comparative effectiveness and differences in reimbursement of minimally invasive radical prostatectomy (MIRP) and open prostatectomy (ORP) in privately insured patients are unknown. Therefore, we sought to assess the differences in perioperative outcomes and hospital reimbursement in a privately insured patient population who were surgically treated for prostate cancer. Methods: Using a large private insurance database, we identified 17 610 prostate cancer patients who underwent either MIRP or ORP from 2003 to 2010. The primary outcomes were length of stay (LOS), perioperative complications, 90-day readmissions rates and hospital reimbursement. Multivariable regression analyses were used to evaluate for differences in primary outcomes across surgical approaches. Results: Overall, 8981 (51.0%) and 8629 (49.0%) surgically treated prostate cancer patients underwent MIRP and ORP, respectively. The proportion of patients undergoing MIRP markedly rose from 11.9% in 2003 to 72.5% in 2010 ( P
ISSN:1365-7852
1476-5608
DOI:10.1038/pcan.2014.38